168 related articles for article (PubMed ID: 32888768)
21. Development of a disability scale for myotonic dystrophy type 1.
Contardi S; Pizza F; Falzone F; D'Alessandro R; Avoni P; Di Stasi V; Montagna P; Liguori R
Acta Neurol Scand; 2012 Jun; 125(6):431-8. PubMed ID: 21902674
[TBL] [Abstract][Full Text] [Related]
22. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
[TBL] [Abstract][Full Text] [Related]
23. Multidimensional aspects of pain in myotonic dystrophies.
Peric M; Peric S; Rapajic N; Dobricic V; Savic-Pavicevic D; Nesic I; Radojicic S; Novakovic I; Lavrnic D; Rakocevic-Stojanovic V
Acta Myol; 2015 Dec; 34(2-3):126-32. PubMed ID: 27199540
[TBL] [Abstract][Full Text] [Related]
24. Body composition and clinical outcome measures in patients with myotonic dystrophy type 1.
Sedehizadeh S; Brook JD; Maddison P
Neuromuscul Disord; 2017 Mar; 27(3):286-289. PubMed ID: 28082208
[TBL] [Abstract][Full Text] [Related]
25. Overground exoskeletons may boost neuroplasticity in myotonic dystrophy type 1 rehabilitation: A case report.
Portaro S; Naro A; Leo A; Cimino V; Balletta T; Buda A; Accorinti M; Calabrò RS
Medicine (Baltimore); 2019 Nov; 98(46):e17582. PubMed ID: 31725606
[TBL] [Abstract][Full Text] [Related]
26. Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status.
Bienias P; Łusakowska A; Ciurzyński M; Rymarczyk Z; Irzyk K; Kurnicka K; Kamińska A; Pruszczyk P
Pacing Clin Electrophysiol; 2016 Sep; 39(9):959-68. PubMed ID: 27444982
[TBL] [Abstract][Full Text] [Related]
27. Value of short exercise and short exercise with cooling tests in the diagnosis of myotonic dystrophies (DM1 and DM2).
Gawel M; Szmidt-Salkowska E; Lusakowska A; Nojszewska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
Muscle Nerve; 2014 Feb; 49(2):277-83. PubMed ID: 23716346
[TBL] [Abstract][Full Text] [Related]
28. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2 : a whole body highfield MRI study.
Kornblum C; Lutterbey G; Bogdanow M; Kesper K; Schild H; Schröder R; Wattjes MP
J Neurol; 2006 Jun; 253(6):753-61. PubMed ID: 16511650
[TBL] [Abstract][Full Text] [Related]
29. Does quantitative EMG differ myotonic dystrophy type 2 and type 1?
Szmidt-Salkowska E; Gawel M; Lusakowska A; Nojszewska M; Lipowska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
J Electromyogr Kinesiol; 2014 Oct; 24(5):755-61. PubMed ID: 25052913
[TBL] [Abstract][Full Text] [Related]
30. Effects of hand-training in persons with myotonic dystrophy type 1--a randomised controlled cross-over pilot study.
Aldehag A; Jonsson H; Lindblad J; Kottorp A; Ansved T; Kierkegaard M
Disabil Rehabil; 2013 Oct; 35(21):1798-807. PubMed ID: 23480644
[TBL] [Abstract][Full Text] [Related]
31. Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness.
Schneider-Gold C; Bellenberg B; Prehn C; Krogias C; Schneider R; Klein J; Gold R; Lukas C
PLoS One; 2015; 10(6):e0130352. PubMed ID: 26114298
[TBL] [Abstract][Full Text] [Related]
32. [Myotonic dystrophies: clinical presentation, pathogenesis, diagnostics and therapy].
Finsterer J; Rudnik-Schöneborn S
Fortschr Neurol Psychiatr; 2015 Jan; 83(1):9-17. PubMed ID: 25602187
[TBL] [Abstract][Full Text] [Related]
33. Myotonic dystrophy health index: Correlations with clinical tests and patient function.
Heatwole C; Bode R; Johnson NE; Dekdebrun J; Dilek N; Eichinger K; Hilbert JE; Logigian E; Luebbe E; Martens W; Mcdermott MP; Pandya S; Puwanant A; Rothrock N; Thornton C; Vickrey BG; Victorson D; Moxley RT
Muscle Nerve; 2016 Feb; 53(2):183-90. PubMed ID: 26044513
[TBL] [Abstract][Full Text] [Related]
34. High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2.
Hilbert JE; Barohn RJ; Clemens PR; Luebbe EA; Martens WB; McDermott MP; Parkhill AL; Tawil R; Thornton CA; Moxley RT;
Neurology; 2017 Sep; 89(13):1348-1354. PubMed ID: 28855409
[TBL] [Abstract][Full Text] [Related]
35. Clinical and genetic heterogeneity in myotonic dystrophies.
Meola G
Muscle Nerve; 2000 Dec; 23(12):1789-99. PubMed ID: 11102902
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic odyssey of patients with myotonic dystrophy.
Hilbert JE; Ashizawa T; Day JW; Luebbe EA; Martens WB; McDermott MP; Tawil R; Thornton CA; Moxley RT
J Neurol; 2013 Oct; 260(10):2497-504. PubMed ID: 23807151
[TBL] [Abstract][Full Text] [Related]
37. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy.
Mathieu J; Boivin H; Meunier D; Gaudreault M; Bégin P
Neurology; 2001 Feb; 56(3):336-40. PubMed ID: 11171898
[TBL] [Abstract][Full Text] [Related]
38. Functioning and disability in adults with myotonic dystrophy type 1.
Kierkegaard M; Harms-Ringdahl K; Holmqvist LW; Tollbäck A
Disabil Rehabil; 2011; 33(19-20):1826-36. PubMed ID: 21254917
[TBL] [Abstract][Full Text] [Related]
39. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
[TBL] [Abstract][Full Text] [Related]
40. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
